Cleave Therapeutics
VerifiedCleave Therapeutics is focused on protein homeostasis and stress pathways in cancer and neurodegeneration.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$48—72m (Dealroom.co estimates Aug 2019.)
San Francisco California (HQ)
No columns specified